← Back to Clinical Trials
RecruitingNCT07306468

Effects of Schizophrenia and Bipolar Disorder on Exercise Capacity, Pulmonary Function, and Quality of Life

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

ConditionSchizophenia Disorder
SponsorÇankırı Karatekin University
Study TypeOBSERVATIONAL
PhaseN/A
Enrollment150
SexALL
Min Age18 Years
Max Age65 Years
Start Date2025-11-01
Completion2026-11-01
Interventions
Pulmonary Function TestRespiratory Muscle Strength EvaluationQuality of Life Assessment

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This observational study aims to evaluate exercise capacity, pulmonary function, respiratory muscle strength, and quality of life in individuals diagnosed with schizophrenia and bipolar disorder. These psychiatric conditions are associated with sedentary lifestyles, metabolic side effects of psychotropic medications, and increased comorbidity risks, all of which may negatively impact physical fitness and respiratory health. By assessing cardiorespiratory endurance, pulmonary parameters (FVC, FEV₁), and respiratory muscle strength in this population, the study seeks to identify physiological limitations and contribute to the development of more effective rehabilitation strategies. The findings may support multidisciplinary approaches to improving physical health and overall quality of life in individuals with severe mental illness.

Eligibility Criteria

Inclusion Criteria: * Being volunteer for participation * Being 18 to 65 age Exclusion Criteria: * Having any respiratory, cardiac, neurologic or orthopedic disease which may affect respiratory functions or exercise capacity * Having any neuropsychiatric disease except schizophrenia or bipolar disorder

Related Trials